Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The value of erlotinib related target molecules in kidney renal cell carcinoma via bioinformatics analysis
YunQiang Zhang, Mingyang Tang, Qiang Guo, et al.
Gene (2022) Vol. 816, pp. 146173-146173
Closed Access | Times Cited: 19

Showing 19 citing articles:

The m6A/m5C/m1A Regulated Gene Signature Predicts the Prognosis and Correlates With the Immune Status of Hepatocellular Carcinoma
Dan Li, Kai Li, Wei Zhang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 82
CLC-Pred 2.0: A Freely Available Web Application for In Silico Prediction of Human Cell Line Cytotoxicity and Molecular Mechanisms of Action for Druglike Compounds
Alexey A. Lagunin, Anastasia V. Rudik, Pavel V. Pogodin, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1689-1689
Open Access | Times Cited: 36
The Risk Model Based on the Three Oxidative Stress-Related Genes Evaluates the Prognosis of LAC Patients
Qiang Guo, Xiaoli Liu, Huasong Liu, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-19
Open Access | Times Cited: 17
Interfering with ITGB1-DT expression delays cancer progression and promotes cell sensitivity of NSCLC to cisplatin by inhibiting the MAPK/ERK pathway.
Dan Li, Xiaoli Liu, Ni Jiang, et al.
PubMed (2022) Vol. 12, Iss. 7, pp. 2966-2988
Closed Access | Times Cited: 17
The Roles and Mechanisms of TRAT1 in the Progression of Non-Small Cell Lung Cancer
Qiang Guo, Si-hua Wang, Yanmei Ji, et al.
Current Medical Science (2022) Vol. 42, Iss. 6, pp. 1186-1200
Closed Access | Times Cited: 9
Advances in Inflammatory Bowel Disease Diagnostics: Machine Learning and Genomic Profiling Reveal Key Biomarkers for Early Detection
Asif Hassan, Hamza A. S. Abujabal, Shakeel Ahmad, et al.
Diagnostics (2024) Vol. 14, Iss. 11, pp. 1182-1182
Open Access | Times Cited: 1
Construction of AP003469.4-miRNAs-mRNAs ceRNA network to reveal potential biomarkers for hepatocellular carcinoma.
Teng-Yang Fan, Guojun Jiang, Rongshu Shi, et al.
PubMed (2022) Vol. 12, Iss. 4, pp. 1484-1501
Closed Access | Times Cited: 8
FMR1 is identified as an immune-related novel prognostic biomarker for renal clear cell carcinoma: A bioinformatics analysis of TAZ/YAP
Sufang Wu, Hua He, Jingjing Huang, et al.
Mathematical Biosciences & Engineering (2022) Vol. 19, Iss. 9, pp. 9295-9320
Open Access | Times Cited: 6
A novel risk model of three gefitinib-related genes FBP1, SBK1 and AURKA is related to the immune microenvironment and is predicting prognosis of lung adenocarcinoma patients
Qiang Guo, Kai Li, Ni Jiang, et al.
Aging (2023) Vol. 15, Iss. 18, pp. 9633-9660
Open Access | Times Cited: 3
A new risk model for CSTA, FAM83A, and MYCT1 predicts poor prognosis and is related to immune infiltration in lung squamous cell carcinoma.
Yu Ding, Tingting Bian, Qianyun Li, et al.
PubMed (2022) Vol. 14, Iss. 11, pp. 7705-7725
Closed Access | Times Cited: 5
PANK1 associates with cancer metabolism and immune infiltration in clear cell renal cell carcinoma: a retrospective prognostic study based on the TCGA database
Bin Wang, Bin Liu, Qing Luo, et al.
Translational Cancer Research (2022) Vol. 11, Iss. 7, pp. 2321-2337
Open Access | Times Cited: 4
Creating and Utilizing an Immune-Related Gene Prognosis Framework for Kidney Clear Cell Carcinoma
Jiahui Luo, Qingbo Zhou
MEDS Basic Medicine (2024) Vol. 2, Iss. 1
Open Access
Understanding of Endomucin: a Multifaceted Glycoprotein Functionality in Vascular Inflammatory‐Related Diseases, Bone Diseases and Cancers
Xiaoqing Li, Qing Lv, Peng Liu, et al.
Advanced Biology (2024) Vol. 8, Iss. 10
Closed Access
Decreased PANK1 expression in kidney renal clear cell carcinoma: impact on cell apoptosis, invasion, migration, and epithelial-mesenchymal transition
Xiang Liu, Song Gao, Ye-Min Qin, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access
SLC25A25-AS1 over-expression could be predicted the dismal prognosis and was related to the immune microenvironment in prostate cancer
Yingying Zhao, Qian-Ming Xiang, Jiali Chen, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 3
The Emerging Roles and Mechanisms of PAQR3 in Human Cancer: Pathophysiology and Therapeutic Implications
Qiang Guo, Xiaoli Liu, Kui Zhai, et al.
International Journal of General Medicine (2023) Vol. Volume 16, pp. 4321-4328
Open Access | Times Cited: 1
Genes associated with inflammation for prognosis prediction for clear cell renal cell carcinoma: a multi-database analysis
Yonggui Xiao, Chonghao Jiang, Hubo Li, et al.
Translational Cancer Research (2023) Vol. 12, Iss. 10, pp. 2629-2645
Open Access | Times Cited: 1
Electrochemical and theoretical study on interaction between erlotinib and DNA
Milan Jovanović, Katarina Nikolić, Marija Čarapić, et al.
Journal of Pharmaceutical and Biomedical Analysis (2023) Vol. 234, pp. 115560-115560
Closed Access
IncRNA VIM-AS1 expression is positively correlated with the prognosis and immune infiltration in lung adenocarcinoma
Jianhong Kang, Maimaiti Abudurufu, Shuwei Zhang, et al.
Research Square (Research Square) (2022)
Open Access
Page 1

Scroll to top